TomoTherapy Issues Treatment Quality Challenge
MADISON, Wis. (Business Wire EON/PRWEB ) March 26, 2008 --
TomoTherapy Incorporated
(NASDAQ:TOMO), maker of the TomoTherapy®
Hi·Art®
treatment system for advanced radiation therapy, announced today that it
has issued a Treatment Quality Challenge. TomoTherapy will award
$250,000 to any U.S. cancer center that demonstrates its ability to beat
the quality of a TomoTherapySM treatment plan
using the new RapidArc™
product from Varian Medical Systems.
“We believe that, even as radiation therapy
vendors work to improve clinical efficiency, the highest-quality patient
treatments must remain our industry’s primary
focus,” said Fred Robertson, CEO of
TomoTherapy. “With this challenge, we aim to
provide a forum for U.S. clinicians to objectively review the quality
that a continuous helical TomoTherapy treatment affords over a
two-minute, single-rotation RapidArc™
delivery.”
Cancer centers are encouraged to learn more about this challenge, and to
register, at TomoTherapy.com.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy®
Hi·Art®
treatment system, an advanced radiation therapy system for the treatment
of a wide variety of cancers. The Hi·Art
treatment system combines integrated CT imaging with conformal radiation
therapy to deliver sophisticated radiation treatments with speed and
precision while reducing radiation exposure to surrounding healthy
tissue. The company’s stock is traded on the
NASDAQ Global Select Market under the symbol TOMO. To learn more about
TomoTherapy, please visit TomoTherapy.com.
©2008 TomoTherapy Incorporated. All rights
reserved. TomoTherapy, the TomoTherapy logo and Hi·Art
are among trademarks, service marks or registered trademarks of
TomoTherapy Incorporated. RapidArc is a trademark of Varian Medical
Systems.
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1Mb3ZlLUluc2UtU3F1YS1TdW1tLVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.